Creative Planning Vbi Vaccines Inc Transaction History

Creative Planning

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $18,923 - $36,803	-14,900 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $32,929 - $47,978	14,900 New	14,900 $35,000
Q2 2021 Aug 04, 2021	SELL	$2.61 - $4.17 $762,347 - $1.22 Million	-292,087 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$2.91 - $4.32 $174,600 - $259,200	-60,000 Reduced 17.04%	292,087 $908,000
Q4 2020 Jan 29, 2021	BUY	$2.15 - $3.5 $686,589 - $1.12 Million	319,344 Added 975.3%	352,087 $968,000
Q3 2020 Nov 05, 2020	SELL	$2.77 - $6.17 $580,351 - $1.29 Million	-209,513 Reduced 86.48%	32,743 $94,000
Q2 2020 Jul 23, 2020	BUY	$0.87 - $3.13 $136,725 - $491,898	157,156 Added 184.67%	242,256 $751,000
Q1 2020 May 05, 2020	BUY	$0.73 - $1.91 $49,713 - $130,071	68,100 Added 400.59%	85,100 $81,000
Q4 2019 Jan 30, 2020	BUY	$0.48 - $1.38 $8,160 - $23,460	17,000 New	17,000 $23,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.